首页|舒肌汤对L-DOPA诱发的帕金森病肌僵直大鼠的作用及其脑组织TH、DA含量和FosB、p-ERK蛋白的影响

舒肌汤对L-DOPA诱发的帕金森病肌僵直大鼠的作用及其脑组织TH、DA含量和FosB、p-ERK蛋白的影响

扫码查看
目的:观察舒肌汤对左旋多巴(Levodopa,L-DOPA)诱发的帕金森病(Parkinson's disease,PD)肌僵直模型大鼠的影响,并探讨其作用机制.方法:L-DOPA诱导建立PD肌僵直大鼠模型,随机分为模型组(等体积生理盐水),舒肌汤低、中、高剂量组(10、20、40 g/kg),同时设假手术组(等体积生理盐水)作为对照,每组6只大鼠,每天灌胃给药1次,连续给药28 d.给药完成后通过旋转次数实验、翻正反射实验、肌电图检测行为学表现.免疫组化检测脑组织酪氨酸羟化酶(tyrosine hydroxylase,TH)表达水平.ELISA检测脑纹状体组织多巴胺(dopamine,DA)和TH的含量.Western blot检测脑纹状体组织FBJ鼠科骨肉瘤病毒癌基因同源物B(FBJ Murine Osteosarcoma Viral Oncogene Homolog B,FosB)、磷酸化细胞外信号调节激酶(phosphorylation-extracellular signal-regulated kinase,p-ERK)蛋白表达水平.结果:与假手术组相比,模型组大鼠旋转次数、翻正反射时间与评分、肌肉动作电位波幅和潜伏期显著升高或延长(P<0.01),MCV显著降低(P<0.01);与模型组相比,舒肌汤组大鼠旋转次数、翻正反射时间与评分、肌肉动作电位波幅和潜伏期显著降低或缩短(P<0.05),MCV显著升高(P<0.01).免疫组化结果显示舒肌汤可上调脑组织TH表达水平;ELISA结果显示舒肌汤可上调DA和TH含量.Western blot结果显示舒肌汤可下调FosB、p-ERK蛋白表达水平.结论:舒肌汤对帕金森病模型大鼠肌僵直有显著疗效,其作用机制可能与上调DA和TH含量、下调FosB、p-ERK蛋白表达有关.
Study on Effects of Shuji Decoction(舒肌汤)on Levodopa-Induced Parkinson's Disease Muscle Rigidity Rat and Striatal Tissue TH,DA Contents and FosB,p-ERK Expressions
Objective:To observe the effects of Shuji Decoction on Levodopa(L-DOPA)induced Parkin-son's disease(PD)muscle rigidity model rats,and explored its mechanism of action.Methods:L-DOPA in-duced the establishment of PD muscle rigidity rat model,Models were randomly divided into model group(equal volume of saline),Shuji Decoction low,medium and high dose groups(1.0,2.0,4.0 g/kg),and a sham-ope-rated group(equal volume of saline)was set up as the control,6 rats in each group,1 time a day continuous administration for 28 d.After completion of drug administration,behavioral performance was detected by rotation count test,rollover reflex test,and electromyography.The expression level of tyrosine hydroxylase(TH)in brain tissue were measured by immunohistochemistry.Dopamine(DA)and TH levels in brain striatum were measured by ELISA.FosB,p-ERK protein expression levels in brain striatum were measured by Western blot.Results:Compared with the sham-operated group,the number of rotations,roll-over reflex time and score,muscle action potential wave amplitude and latency time were significantly higher or longer(P<0.01)and MCV was significantly lower(P<0.01)in the model group;compared with the model group,the number of rotations,roll-over reflex time and score,muscle action potential wave amplitude and latency time were significantly lower of shorter(P<0.05)and MCV was significantly higher(P<0.01)in Shuji Decoction groups.Immunohistochemistry results showed that Shuji Decoction could up-regulate the expression level of TH.ELISA results showed that Shuji Decoction could up-regulate the contents of DA and TH in striatum.Western blot results showed that Shuji Decoction could down-regulate the expression levels of FosB and p-ERK protein.Conclusion:Shuji Decoction showed significant efficacy in Parkinson's disease muscle rigidity model rats,and its mechanism of action may be related to the up-regulation of DA and TH contents and down-regulation of FosB and p-ERK protein expressions.

Parkinson's diseasemuscle rigidityLevodopaShuji Decoctiondopamine(DA)tyrosine hydroxylase(TH)FosBp-ERKrat

刘超平、孙婷、鲍玺

展开 >

湖州市第三人民医院·浙江湖州 313000

浙江中医药大学附属杭州市中医院·浙江杭州 310007

帕金森病 肌僵直 左旋多巴 舒肌汤 多巴胺 酪氨酸氢化酶 FosB p-ERK 大鼠

2024

中国中医药科技
中华中医药学会

中国中医药科技

影响因子:1.156
ISSN:1005-7072
年,卷(期):2024.31(5)